NovelStem International Corp.
NSTM· OTC
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001493152-26-038089
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$85.80K | $2.75M | -$302.63K | -$2.87M |
| EPS Diluted | $0.00 | $0.06 | -$0.01 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NovelStem International Corp. · CIK 912544 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end